196 related articles for article (PubMed ID: 23553674)
1. Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction.
Babick A; Elimban V; Zieroth S; Dhalla NS
J Cell Physiol; 2013 Oct; 228(10):2063-70. PubMed ID: 23553674
[TBL] [Abstract][Full Text] [Related]
2. Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction.
Babick A; Chapman D; Zieroth S; Elimban V; Dhalla NS
J Cell Mol Med; 2012 Dec; 16(12):2958-67. PubMed ID: 22947202
[TBL] [Abstract][Full Text] [Related]
3. Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.
Shao Q; Ren B; Zarain-Herzberg A; Ganguly PK; Dhalla NS
J Mol Cell Cardiol; 1999 Sep; 31(9):1663-72. PubMed ID: 10471350
[TBL] [Abstract][Full Text] [Related]
4. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
Maczewski M; Mackiewicz U
Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
[TBL] [Abstract][Full Text] [Related]
5. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
[TBL] [Abstract][Full Text] [Related]
7. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
8. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan.
Liu X; Sentex E; Golfman L; Takeda S; Osada M; Dhalla NS
Clin Exp Hypertens; 1999; 21(1-2):145-56. PubMed ID: 10052650
[TBL] [Abstract][Full Text] [Related]
9. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan.
Guo X; Chapman D; Dhalla NS
Mol Cell Biochem; 2003 Dec; 254(1-2):163-72. PubMed ID: 14674695
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515
[TBL] [Abstract][Full Text] [Related]
11. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
Wang J; Guo X; Dhalla NS
Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
Machackova J; Sanganalmath SK; Barta J; Dhalla KS; Dhalla NS
Cardiovasc Toxicol; 2010 Mar; 10(1):9-16. PubMed ID: 19949891
[TBL] [Abstract][Full Text] [Related]
13. Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure.
Gupta RC; Mishra S; Mishima T; Goldstein S; Sabbah HN
J Mol Cell Cardiol; 1999 Jul; 31(7):1381-9. PubMed ID: 10403755
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
[TBL] [Abstract][Full Text] [Related]
15. Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment.
Shao Q; Ren B; Saini HK; Netticadan T; Takeda N; Dhalla NS
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1674-82. PubMed ID: 15576437
[TBL] [Abstract][Full Text] [Related]
16. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA).
Pennock GD; Spooner PH; Summers CE; Litwin SE
J Mol Cell Cardiol; 2000 Nov; 32(11):1939-53. PubMed ID: 11040100
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
Pantos C; Mourouzis I; Markakis K; Dimopoulos A; Xinaris C; Kokkinos AD; Panagiotou M; Cokkinos DV
Eur J Cardiothorac Surg; 2007 Aug; 32(2):333-9. PubMed ID: 17560116
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure.
Sanganalmath SK; Babick AP; Barta J; Kumamoto H; Takeda N; Dhalla NS
J Cell Mol Med; 2008; 12(5A):1728-38. PubMed ID: 18088389
[TBL] [Abstract][Full Text] [Related]
19. Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Shah KR; Ganguly PK; Netticadan T; Arneja AS; Dhalla NS
Can J Physiol Pharmacol; 2004 Jul; 82(7):438-47. PubMed ID: 15389290
[TBL] [Abstract][Full Text] [Related]
20. Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
Omerovic E; Bollano E; Mobini R; Madhu B; Kujacic V; Soussi B; Hjalmarson A; Waagstein F
Biochem Biophys Res Commun; 2001 Feb; 281(2):491-8. PubMed ID: 11181074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
